Fundamentals

METROPOLIS HEALTHCARE LTD 

Ticker : 542650
BUY: Rs. 980.05 Target:
Rs. 1090.00



Metropolis Healthcare Ltd. is a diagnostic company providing pathological services. The company offers a range of products such as clinical laboratory tests and profiles, diagnostic screening, confirmation and monitoring of a disease, blood tests, viral and bacterial cultures, autoimmunity tests, etc. The company was listed on the exchanges in April 2019. On the financial front, the company has reported a growth in revenue by 21.1 per cent to Rs 2,008 mn for Q4FY19 from Rs. 1,658 mn for Q4FY18. The PBT stood at Rs 519 mn and Rs 447 mn for Q4FY19 and Q4FY18, respectively. The net profit in Q4FY19 was Rs. 348 mn, an increase of 14.2 percent over the net profit of Rs. 305 mn in Q4FY18. It is launching a new wellness initiative TruHealth. Metropolis Healthcare is also expanding its geographical presence to capture future growth opportunities. Thus, we recommend a BUY.